(Q37132961)

18 August 2017

Use of imatinib in the prevention of heterotopic ossification (English)

1 reference

18 August 2017

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Clément M L Werner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Stefan M Zimmermann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Carola C Würgler-Hauri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Joseph M Lane

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Guido A Wanner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

21 June 2013

1 reference

18 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

166-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11420-013-9335-y

1 June 2020

exact match

0 references

cites work

Dysregulation of bone remodeling by imatinib mesylate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Cox-2 Selective Inhibitors and Bone

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Pathologic bone formation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

A clinical perspective on common forms of acquired heterotopic ossification

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinib

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Long-term imatinib therapy promotes bone formation in CML patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Imatinib as a potential antiresorptive therapy for bone disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

COX-2 selective NSAID decreases bone ingrowth in vivo

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Antiangiogenic treatment delays chondrocyte maturation and bone formation during limb skeletogenesis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757489

Scoliosis in patients with Duchenne muscular dystrophy

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11420-013-9335-Y

Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate

21 January 2018

1 reference

12 December 2020

Effect of platelet-derived growth factor on tibial osteotomies in rabbits

1 reference

12 December 2020

The effect of diphosphonates on heterotopic ossification in regenerating achilles tendon of the mouse

1 reference

12 December 2020

Heterotopic ossification

1 reference

12 December 2020

Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial

1 reference

12 December 2020

Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation

1 reference

12 December 2020

10.1007/S11420-013-9335-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24426864%20AND%20SRC:MED&resulttype=core&format=json